Syncom Formulations (India) Limited - Asset Resilience Ratio

Latest as of September 2025: 31.53%

Syncom Formulations (India) Limited (SYNCOMF) has an Asset Resilience Ratio of 31.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Syncom Formulations (India) Limited debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs1.44 Billion

≈ $15.55 Million USD Cash + Short-term Investments

Total Assets

Rs4.56 Billion

≈ $49.32 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Syncom Formulations (India) Limited's Asset Resilience Ratio has changed over time. See SYNCOMF book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Syncom Formulations (India) Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Syncom Formulations (India) Limited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs1.44 Billion	31.53%
Total Liquid Assets	Rs1.44 Billion	31.53%

Asset Resilience Insights

Very High Liquidity: Syncom Formulations (India) Limited maintains exceptional liquid asset reserves at 31.53% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Syncom Formulations (India) Limited Industry Peers by Asset Resilience Ratio

Compare Syncom Formulations (India) Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
KPC Pharmaceuticals Inc SHG:600422	Drug Manufacturers - Specialty & Generic	16.37%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Cheng Du Sheng Nuo Biotec Co. Ltd. A SHG:688117	Drug Manufacturers - Specialty & Generic	3.51%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	5.72%

Annual Asset Resilience Ratio for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Syncom Formulations (India) Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	21.59%	Rs892.16 Million ≈ $9.65 Million	Rs4.13 Billion ≈ $44.69 Million	+4.74pp
2024-03-31	16.85%	Rs681.82 Million ≈ $7.37 Million	Rs4.05 Billion ≈ $43.76 Million	-1.68pp
2023-03-31	18.53%	Rs700.17 Million ≈ $7.57 Million	Rs3.78 Billion ≈ $40.86 Million	+5.54pp
2022-03-31	12.99%	Rs400.31 Million ≈ $4.33 Million	Rs3.08 Billion ≈ $33.33 Million	-11.47pp
2021-03-31	24.46%	Rs713.42 Million ≈ $7.72 Million	Rs2.92 Billion ≈ $31.54 Million	+24.26pp
2020-03-31	0.20%	Rs3.62 Million ≈ $39.15K	Rs1.81 Billion ≈ $19.52 Million	-0.09pp
2019-03-31	0.30%	Rs5.11 Million ≈ $55.25K	Rs1.73 Billion ≈ $18.71 Million	-2.72pp
2018-03-31	3.01%	Rs51.49 Million ≈ $556.83K	Rs1.71 Billion ≈ $18.49 Million	+2.63pp
2017-03-31	0.38%	Rs6.90 Million ≈ $74.62K	Rs1.80 Billion ≈ $19.48 Million	+0.31pp
2015-03-31	0.08%	Rs1.07 Million ≈ $11.55K	Rs1.38 Billion ≈ $14.88 Million	-1.23pp
2006-03-31	1.31%	Rs6.20 Million ≈ $67.04K	Rs473.07 Million ≈ $5.12 Million	--

pp = percentage points

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic

Market Cap

$149.13 Million

Rs13.79 Billion INR

Market Cap Rank

#17678 Global

#921 in India

Share Price

Rs14.67

Change (1 day)

-1.94%

52-Week Range

Rs10.30 - Rs22.15

All Time High

Rs26.77